These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31712777)

  • 61. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management.
    Maciocia N; Wechalekar A; Yong K
    Hematol Oncol; 2017 Dec; 35(4):432-439. PubMed ID: 27804161
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Defining genomic events involved in the evolutionary trajectories of myeloma and its precursor conditions.
    Chojnacka M; Diamond B; Landgren O; Maura F
    Semin Oncol; 2022 Feb; 49(1):11-18. PubMed ID: 35168813
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Frequency of chromosomal abnormalities in Pakistani adults with acute lymphoblastic leukemia.
    Shaikh MS; Adil SN; Shaikh MU; Khurshid M
    Asian Pac J Cancer Prev; 2014; 15(21):9495-8. PubMed ID: 25422245
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
    Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
    Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular cytogenetic characterization of two small supernumerary marker chromosomes derived from chromosome 19.
    Dennis TR; Raptoulis GN; Stalker HJ; Boles D; Meck JM; Krasnewich DM; Schiffmann R; Zori RT
    Am J Med Genet A; 2009 Feb; 149A(2):262-5. PubMed ID: 19133694
    [No Abstract]   [Full Text] [Related]  

  • 66. Reversal of skin changes in smoldering myeloma with clinical presentation of POEMS syndrome with a lenalidomide-based regimen.
    Solomou EE; Marnellos P; Agathokleous A; Kyriakou G; Georgiou S; Symeonidis A
    Ann Hematol; 2019 Nov; 98(11):2625-2626. PubMed ID: 31650288
    [No Abstract]   [Full Text] [Related]  

  • 67. Smoldering multiple myeloma.
    Rajkumar SV; Landgren O; Mateos MV
    Blood; 2015 May; 125(20):3069-75. PubMed ID: 25838344
    [TBL] [Abstract][Full Text] [Related]  

  • 68. State of the science in smoldering myeloma: Should we be treating in the clinic?
    Hill E; Dew A; Kazandjian D
    Semin Oncol; 2019 Apr; 46(2):112-120. PubMed ID: 31072611
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Cytogenetic characteristics of human blood lymphocytes in vivo in a 120-day bedrest study].
    Repina LA; Repin MV
    Aviakosm Ekolog Med; 2009; 43(6):59-60. PubMed ID: 20169743
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.
    Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD
    Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma.
    Salem DA; Korde N; Venzon DJ; Liewehr DJ; Maric I; Calvo KR; Braylan R; Tembhare PR; Yuan CM; Landgren CO; Stetler-Stevenson M
    Leuk Lymphoma; 2018 Jan; 59(1):178-186. PubMed ID: 28540748
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Crystal-storing histiocytosis associated with smoldering myeloma.
    de Haart SJ; Leguit RJ
    Blood; 2021 Jul; 138(4):354. PubMed ID: 34323945
    [No Abstract]   [Full Text] [Related]  

  • 73. Genomic analysis of high-risk smoldering multiple myeloma.
    López-Corral L; Mateos MV; Corchete LA; Sarasquete ME; de la Rubia J; de Arriba F; Lahuerta JJ; García-Sanz R; San Miguel JF; Gutiérrez NC
    Haematologica; 2012 Sep; 97(9):1439-43. PubMed ID: 22331267
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chromosomal and genetic abnormalities in myeloma.
    Joy Ho P
    Clin Lab Haematol; 2002 Oct; 24(5):259-69. PubMed ID: 12358886
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genomic profiling of myeloma: the best approach, a comparison of cytogenetics, FISH and array-CGH of 112 myeloma cases.
    Rack K; Vidrequin S; Dargent JL
    J Clin Pathol; 2016 Jan; 69(1):82-6. PubMed ID: 26338801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cytogenetic clonal evolution in myeloproliferative neoplasms: contexts and prognostic impact among 648 patients with serial bone marrow biopsies.
    Tefferi A; Nicolosi M; Penna D; Vallapureddy R; Hanson CA; Pardanani A; Gangat N; Ketterling RP
    Leukemia; 2019 Oct; 33(10):2522-2553. PubMed ID: 31040370
    [No Abstract]   [Full Text] [Related]  

  • 77. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients.
    Cuneo A; Balsamo R; Roberti MG; Bardi A; Piva N; Balboni M; Bigoni R; Rigolin GM; Castoldi G
    Cancer Genet Cytogenet; 1996 Sep; 90(2):171-5. PubMed ID: 8830729
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Future aspect of cytogenetics using chromosomal microarray testing].
    Yamamoto T
    Rinsho Byori; 2014 Jan; 62(1):75-82. PubMed ID: 24724430
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clonal evolution of one rare case of multiple myeloma with bilateral testicular mass as initial presentation.
    Lin N; Wu Y; Liang Y; Mo W; Li Y; Zhang R
    Ann Hematol; 2020 Feb; 99(2):377-378. PubMed ID: 31879789
    [No Abstract]   [Full Text] [Related]  

  • 80. Overview of cytogenetic chromosome analysis.
    Bayani J; Squire JA
    Curr Protoc Cell Biol; 2004 Sep; Chapter 22():Unit 22.1. PubMed ID: 18228452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.